Adjuvant chemotherapy with S-1 after curative treatment in patients with head and neck cancer (ACTS-HNC).
Takahide Taguchi
No relevant relationships to disclose
Akira Kubota
No relevant relationships to disclose
Kunitoshi Yoshino
No relevant relationships to disclose
Kichinobu Tomita
Honoraria - Taiho Pharmaceutical
Research Funding - Taiho Pharmaceutical
Naoyuki Kohno
No relevant relationships to disclose
Kazuyoshi Kawabata
No relevant relationships to disclose
Masaori Fukushima
No relevant relationships to disclose
Kiyoaki Tsukahara
No relevant relationships to disclose
Hideki Takemura
Honoraria - Taiho Pharmaceutical
Yasuhisa Hasegawa
No relevant relationships to disclose
Tomonori Terada
No relevant relationships to disclose
Kunihiko Nagahara
No relevant relationships to disclose
Hiroaki Nakatani
No relevant relationships to disclose
Yuichiro Higaki
No relevant relationships to disclose
Shigemichi Iwae
No relevant relationships to disclose
Takashi Beppu
No relevant relationships to disclose
Yutaka Hanamure
No relevant relationships to disclose
Satoshi Teramukai
Consultant or Advisory Role - Taiho Pharmaceutical
Honoraria - Taiho Pharmaceutical
Masato Fujii
No relevant relationships to disclose